Cleared Special

K210838 - PROWLER SELECT PLUS

Also marketed or referenced as:
PROWLER EX

K210838 is the FDA 510(k) clearance for PROWLER SELECT PLUS by Medos International SARL. It is a Class 2 Neurology device (product code KRA) cleared through the Special 510(k) pathway after a 156-day FDA review.

K210838 · Medos International SARL · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
156d
Days
Class 2
Risk

K210838 is an FDA 510(k) clearance for the PROWLER SELECT PLUS. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Medos International SARL (Le Locle, CH). The FDA issued a Cleared decision on August 25, 2021 after a review of 156 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1210 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medos International SARL devices

Submission Details

510(k) Number K210838 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 2021
Decision Date August 25, 2021
Days to Decision 156 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 148d · This submission: 156d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Cerenovus
Samuel Shimp

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KRA Catheter, Continuous Flush

All 127
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K210838.
PROWLER SELECT LP ES Microcatheter
K214025 · Medos International SARL · Apr 2022
Micro Catheter and Guidewire System
K212719 · Suzhou Hengrui Hongyuan Medical Co., Ltd. · Apr 2022
Agile Devices Angler Steerable, Deflectable Microcatheter
K211110 · Agile Devices, Inc. · Jan 2022
Bullfrog Micro-Infusion Device
K210339 · Mercator Medsystems, Inc. · Aug 2021
SwiftNINJA Steerable Microcatheter
K211525 · Merit Medical Systems, Inc. · Jul 2021
Instylla Microcatheter 1.2
K210808 · Instylla, Inc. · Apr 2021